This article is about a medication under development by ViiV called, Fostemsavir. ViiV is a mostly Gilead owned company, but at least it's not another Truvada knock-off. Many newer medications have been developed by pharma conglomerates. This new medication is primarily being aimed at people with HIV that is resistant to most other meds. This could be something big. It'll be a bit, before it comes to market though. Something else to watch for in the future.
Cya..
No comments:
Post a Comment